Otello Stampacchia's Net Worth
$385 Million
Who is Otello Stampacchia?
Otello Stampacchia has an estimated net worth of $385 Million. This is based on reported shares across multiple companies, which include MICROMET, INC., Paratek Pharmaceuticals, Inc., Nuvation Bio Inc., Morphic Holding, Inc., Lexeo Therapeutics, Inc., Kezar Life Sciences, Inc., IMMUNIC, INC., Gossamer Bio, Inc., Theseus Pharmaceuticals, Inc., Kronos Bio, Inc., Replimune Group, Inc., Ikena Oncology, Inc., Translate Bio, Inc., and Omega Alpha SPAC.
SEC CIK
Otello Stampacchia's CIK is 0001361712
Past Insider Trading and Trends
2018 was Otello Stampacchia's most active year for acquiring shares with 14 total transactions. Otello Stampacchia's most active month to acquire stocks was the month of June. 2021 was Otello Stampacchia's most active year for disposing of shares, totalling 229 transactions. Otello Stampacchia's most active month to dispose stocks was the month of February. 2020 saw Otello Stampacchia paying a total of $46,931,457.50 for 20,497,097 shares, this is the most they've acquired in one year. In 2010 Otello Stampacchia cashed out on 1,709,000 shares for a total of $13,824,369.15, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Nuvation Bio Inc. (NUVB) Snapshot price: $1.635
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +44.07% | 8.63M |
$10.00 |
—
| 28.21M |
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Morphic Holding, Inc. (MORF) Snapshot price: $38.15
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.82% | -17.16K |
$54.65 | -$937,661.84 | 2.07M |
Scheduled
|
Apr 29 - Apr 30
| ||
Form 4
| -0.51% | -10.70K |
$55.42 | -$593,253.66 | 2.09M |
Scheduled
|
Apr 27 - Apr 28
| ||
Form 4
| -0.65% | -13.82K |
$56.00 | -$773,768.65 | 2.1M |
Scheduled
|
Apr 23 - Apr 26
| ||
Form 4
| -0.93% | -19.79K |
$57.07 | -$1,129,260.34 | 2.11M |
Scheduled
|
Apr 21 - Apr 22
| ||
Form 4
| -0.83% | -17.87K |
$54.30 | -$970,506.43 | 2.13M |
Scheduled
|
Apr 19 - Apr 20
| ||
Form 4
| -0.82% | -17.75K |
$55.62 | -$987,120.93 | 2.15M |
Scheduled
|
Apr 15 - Apr 16
| ||
Form 4
| -0.96% | -20.94K |
$57.49 | -$1,203,506.23 | 2.17M |
Scheduled
|
Apr 13 - Apr 14
| ||
Form 4
| -1.12% | -24.81K |
$58.00 | -$1,439,043.56 | 2.19M |
Scheduled
|
Apr 9 - Apr 12
| ||
Form 4
| -1.19% | -26.68K |
$60.79 | -$1,622,083.77 | 2.21M |
Scheduled
|
Apr 7 - Apr 8
| ||
Form 4
| -0.90% | -20.42K |
$61.58 | -$1,257,689.69 | 2.24M |
Scheduled
|
Apr 5 - Apr 6
| ||
Form 4
| -1.33% | -30.41K |
$63.93 | -$1,943,933.67 | 2.26M |
Scheduled
|
Mar 31 - Apr 1
| ||
Form 4
| -1.55% | -36.08K |
$60.31 | -$2,175,567.05 | 2.29M |
Scheduled
|
Mar 29 - Mar 30
| ||
Form 4
| -2.02% | -47.94K |
$58.67 | -$2,812,522.05 | 2.33M |
Scheduled
|
Mar 25 - Mar 26
| ||
Form 4
| -2.16% | -52.31K |
$60.52 | -$3,166,055.32 | 2.37M |
Scheduled
|
Mar 23 - Mar 24
| ||
Form 4
| -1.05% | -25.78K |
$63.96 | -$1,648,989.94 | 2.43M |
Scheduled
|
Mar 19 - Mar 22
| ||
Form 4
| -0.72% | -35.85K |
$64.07 | -$2,296,266.45 | 4.92M |
Scheduled
|
Mar 17 - Mar 18
| ||
Form 4
| -0.85% | -64.39K |
$65.95 | -$4,190,471.44 | 7.52M |
Scheduled
|
Mar 15 - Mar 16
| ||
Form 4
| -1.39% | -35.99K |
$36.70 | -$1,320,706.83 | 2.55M |
Scheduled
|
Feb 25 - Mar 1
| ||
Form 4
| -0.41% | -10.55K |
$34.16 | -$360,312.90 | 2.59M |
Scheduled
|
Feb 23 - Feb 24
| ||
Form 4
| -0.42% | -10.86K |
$35.18 | -$382,043.62 | 2.6M |
Scheduled
|
Feb 19 - Feb 22
| ||
Form 4
| -0.62% | -16.16K |
$35.38 | -$571,564.72 | 2.61M |
Scheduled
|
Feb 17 - Feb 18
| ||
Form 4
| -0.32% | -8.39K |
$36.90 | -$309,548.28 | 2.63M |
Scheduled
|
Feb 12 - Feb 16
| ||
Form 4
| -0.38% | -10.07K |
$37.63 | -$379,016.26 | 2.63M |
Scheduled
|
Feb 10 - Feb 11
| ||
Form 4
| -0.83% | -22.08K |
$39.65 | -$875,693.86 | 2.64M |
Scheduled
|
Feb 8 - Feb 9
| ||
Form 4
| -0.57% | -15.42K |
$38.08 | -$587,182.27 | 2.67M |
Scheduled
|
Feb 4 - Feb 5
| ||
Form 4
| -1.97% | -54.12K |
$37.05 | -$2,005,517.05 | 2.69M |
Scheduled
|
Feb 2 - Feb 3
| ||
Form 4
| -0.74% | -20.54K |
$33.73 | -$692,922.86 | 2.74M |
Scheduled
|
Jan 29 - Feb 1
| ||
Form 4
| -0.74% | -20.74K |
$32.77 | -$679,529.64 | 2.76M |
Scheduled
|
Jan 27 - Jan 28
| ||
Form 4
| -0.28% | -15.91K |
$32.28 | -$506,503.22 | 5.57M |
Scheduled
|
Jan 25 - Jan 26
| ||
Form 4
| -0.36% | -10.01K |
$30.74 | -$307,524.82 | 2.8M |
Scheduled
|
Jan 21 - Jan 22
| ||
Form 4
| -0.61% | -17.24K |
$30.04 | -$517,887.90 | 2.81M |
Scheduled
|
Jan 19
| ||
Form 4
| -0.41% | -23.53K |
$30.44 | -$718,480.84 | 5.68M |
Scheduled
|
Jan 14 - Jan 15
| ||
Form 4
| -0.44% | -12.50K |
$30.11 | -$376,257.20 | 2.85M |
Scheduled
|
Jan 12 - Jan 13
| ||
Form 4
| -0.43% | -12.41K |
$30.14 | -$373,950.81 | 2.86M |
Scheduled
|
Jan 8 - Jan 11
| ||
Form 4
| -0.97% | -28.16K |
$30.03 | -$845,829.99 | 2.88M |
Scheduled
|
Jan 6 - Jan 7
| ||
Form 4
| -0.87% | -25.44K |
$31.85 | -$810,393.44 | 2.9M |
Scheduled
|
Jan 4 - Jan 5
| ||
Form 4
| -0.54% | -15.89K |
$33.01 | -$524,573.06 | 2.93M |
Scheduled
|
Dec 30 - Dec 31
| ||
Form 4
| -0.67% | -19.89K |
$32.04 | -$637,415.51 | 2.95M |
Scheduled
|
Dec 28 - Dec 29
| ||
Form 4
| -0.40% | -12.03K |
$33.21 | -$399,381.61 | 2.97M |
Scheduled
|
Dec 23 - Dec 24
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
∞
| 2.97M |
$15.00 |
—
| 2.97M |
Jul 1
| |||
Form 4
|
∞
| 2.97M |
$15.00 |
—
| 2.97M |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lexeo Therapeutics, Inc. (LXEO) Snapshot price: $16.29
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.16M |
$11.00 |
—
| 2.16M |
Nov 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kezar Life Sciences, Inc. (KZR) Snapshot price: $0.949
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.39M |
—
|
—
| 1.39M |
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IMMUNIC, INC. (IMUX) Snapshot price: $1.27
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||